Prevalence and diagnosis of severe pulmonary hypertension in patients with chronic obstructive pulmonary disease

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 2, 2007, Pages 114-119

  Mal, Hervé ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Chronic obstructive pulmonary disease; Hemodynamics; Pulmonary hypertension

Indexed keywords

AIRWAY OBSTRUCTION; CARDIOVASCULAR SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE MARKER; DISEASE SEVERITY; DYSPNEA; EXERCISE; HUMAN; HYPOXEMIA; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; PROGNOSIS; PULMONARY HYPERTENSION; RESPIRATORY SYSTEM; REVIEW; VASCULAR DISEASE;

FORCED EXPIRATORY VOLUME; HUMANS; HYPERTENSION, PULMONARY; PREVALENCE; PULMONARY ARTERY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 33846646084     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32801d217f     Document Type: Review

References (22)

1. Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 2003; 21:892-905.
2. Weitzenblum E, Chaouat A. Pulmonary hypertension due to chronic hypoxic lung disease. In: Peacock AJ, Rubin LW, editors. Pulmonary circulation. London: Arnold; 2004. pp. 374-386.
3. Burrows B, Kettel LJ, Niden AH, et al. Patterns of cardiovascular dysfunction in chronic obstructive lung disease. N Engl J Med 1972; 286:912-918.
4. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43:5S-12S.
5. Oswald-Mammosser M, Apprill M, Bachez P, et al. Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type. Respiration 1991; 58:304-310.
6. Scharf SM, Iqbal M, Keller C, et al. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002; 166:314-322.
7. Galie N,Manes A, Uguccioni L, et al. Primary pulmonary hypertension: insights into pathogenesis from epidemiology. Chest 1998; 114:184S-194S.
8. Weitzenblum E, Sautegeau A, Ehrhart M, et al. Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 130:993-998.
9. Kessler R, Faller M, Weitzenblum E, et al. 'Natural history' of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164:219-224.
10. Weitzenblum E, Hirth C, Ducolone A, et al. The prognostic significance of pulmonary arterial hypertension in chronic obstructive airway disease [in French]. Poumon Coeur 1981; 37:177-184.
11. Kessler R, Faller M, Fourgaut G, et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 158-164.
12. Madden BP, Allenby M, Loke TK, Sheth A. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease. Vasc Pharmacol 2006; 44:372-376.
13. Ghofrani HA, Voswinckel R, Reichenberger F, et al. Hypoxia- and nonhypoxia-related pulmonary hypertension. Established and new therapies. Cardiovasc Res 2006; 72:30-40.
14. Alp S, Skrygan M, Schmidt WE, Bastian A. Sildenafil improves hemodynamic parameters in COPD - an investigation of six patients. Pulm Pharmacol Ther 2006; 19:386-390.
15. Eddahibi S, Chaouat A, Morrell N, et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003; 108:1839-1844.
16. Eddahibi S, Chaouat A, Tu L, et al. Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3:475-476.
17. Stevens D, Sharma K, Szidon P, et al. Severe pulmonary hypertension associated with COPD. Ann Transplant 2000; 5:8-12.
18. Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127:1531-1536. By means of an original approach (cluster analysis), the authors have been able to describe the main functional/hemodynamic characteristics of disproportionate PH.
19. Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172:189-194. This study gives probably the most pertinent estimation of the prevalence of disproportionate PH in COPD and provides an important information on these patients (clinical/functional/hemodynamic profile and prognosis).
20. Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003; 167:735-740.
21. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52:3792-3800. An excellent paper providing a real life screening of PH in patients with systemic sclerosis. This model helped us to build an algorithm permitting the detection of disproportionate PH in COPD.
22. Leuchte HH, Baumgartner RA, Nounou ME, et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006; 173:744-750. Excellent paper demonstrating the prognostic value of PH in several forms of chronic lung diseases including COPD and suggesting that brain natriuretic peptide dosage could be helpful to identify patients with significant PH.